T2 Biosystems (TTOO) Tops Q3 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
T2 Biosystems Reports Third Quarter 2018 Financial Results and Provides Corporate Update
November 1, 2018 4:01 PM EDTQuarterly Product Revenue Up 71% Year-Over-Year
Reiterates 2018 Financial Guidance
LEXINGTON, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today the operating highlights and financial results for the third quarter ended September 30, 2018. Â
Third Quarter Business and Financial Performance Highlights:
Reported third quarter total revenue of $2.5 million, up 127% year-over-year.Reported third quarter product revenue of over $1.2 million, up 71%... More